Rapamycin inhibits human in stent restenosis vascular smooth muscle cells independently of pRB phosphorylation and p53

Cardiovascular Research

Volumn 66, Issue 3, 2005, Pages 601-610

  Rosner, Dalya ^a   McCarthy, Nicola ^a   Bennett, Martin ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Atherosclerosis; Restenosis; Smooth muscle; Stents

Indexed keywords

COLLAGEN; CYCLOHEXIMIDE; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN P53; PROTEIN P70; RAPAMYCIN; RETINOBLASTOMA PROTEIN;

ARTICLE; CELL ASSAY; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DISRUPTION; CELL ISOLATION; CELL PROLIFERATION; CELL SIZE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; EXAMINATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROSCOPY; NITROBLUE TETRAZOLIUM TEST; PHASE TRANSITION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RESTENOSIS; SMOOTH MUSCLE FIBER; STENT; TIME; VASCULAR SMOOTH MUSCLE; VIDEORECORDING; WESTERN BLOTTING;

ANTIMITOTIC AGENTS; CELL PROLIFERATION; CELLS, CULTURED; CORONARY RESTENOSIS; DEPRESSION, CHEMICAL; HUMANS; INTERPHASE; MUSCLE, SMOOTH, VASCULAR; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIROLIMUS; STENTS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 19444369860     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.01.006     Document Type: Article

References (37)

1. J.E. Sousa, M.A. Costa, A. Abizaid, A.G. Sousa, F. Feres, and L.A. Mattos Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study Circulation 107 2003 24 27
2. M.C. Morice, P.W. Serruys, J.E. Sousa, J. Fajadet, E. Ban Hayashi, and M. Perin A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N. Engl. J. Med. 346 2002 1773 1780
3. F. Tanner, M. Boehm, L. Akyürek, H. San, Z.-Y. Yang, and J. Tashiro Differential effects of the cyclin-dependent kinase inhibitors p27Kip1, p21Cip1 and p16Ink4 on vascular smooth muscle cell proliferation Circulation 101 2000 2022 2025
4. N. Takuwa, Y. Fukui, and Y. Takuwa Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts Mol. Cell. Biol. 19 1999 1346 1358
5. D. Zohlnhofer, T.G. Nuhrenberg, F.J. Neumann, T. Richter, A.E. May, and R. Schmidt Rapamycin effects transcriptional programs in smooth muscle cells controlling proliferative and inflammatory properties Mol. Pharmacol. 65 2004 880 889
6. 1-prolongation of NIH3T3 cells Oncogene 13 1996 1765 1771
7. Y. Luo, S.O. Marx, H. Kiyokawa, A. Koff, J. Massague, and A.R. Marks Rapamycin resistance tied to defective regulation of p27Kip1 Mol. Cell. Biol. 16 1996 6744 6751
8. M. Roque, E.D. Reis, C. Cordon-Cardo, M.B. Taubman, J.T. Fallon, and V. Fuster Effect of p27 deficiency and rapamycin on intimal hyperplasia: in vivo and in vitro studies using a p27 knockout mouse model Lab. Invest. 81 2001 895 903
9. A.R. Marks Rapamycin: signaling in vascular smooth muscle Transplant. Proc. 35 2003 231S 233S
10. R.C. Braun-Dullaeus, M.J. Mann, U. Seay, L. Zhang, H.E. von Der Leyen, and R.E. Morris Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin Arterioscler. Thromb. Vasc. Biol. 21 2001 1152 1158
11. S.L. Schreiber Chemistry and biology of the immunophilins and their immunosuppressive ligands Science 251 1991 283 287
12. D.C. Fingar, C.J. Richardson, A.R. Tee, L. Cheatham, C. Tsou, and J. Blenis mTOR controls cell cycle progression through its cell growth effectors S6K1 and 4E-BP1/eukaryotic translation initiation factor 4E Mol. Cell. Biol. 24 2004 200 216
13. D. Feigenblum, and R.J. Schneider Cap-binding protein (eukaryotic initiation factor 4E) and 4E-inactivating protein BP-1 independently regulate cap-dependent translation Mol. Cell. Biol. 16 1996 5450 5457
14. L.M. Graves, K.E. Bornfeldt, G.M. Argast, E.G. Krebs, X. Kong, and T.A. Lin cAMP- and rapamycin-sensitive regulation of the association of eukaryotic initiation factor 4E and the translational regulator PHAS-I in aortic smooth muscle cells Proc. Natl. Acad. Sci. U. S. A. 92 1995 7222 7226
15. T.A. Lin, X. Kong, T.A. Haystead, A. Pause, G. Belsham, and N. Sonenberg PHAS-I as a link between mitogen-activated protein kinase and translation initiation Science 266 1994 653 656
16. P.J. Blackshear, D.J. Stumpo, E. Carballo, and J.C. Lawrence Jr. Disruption of the gene encoding the mitogen-regulated translational modulator PHAS-I in mice J. Biol. Chem. 272 1997 31510 31514
17. S.O. Marx, and A.R. Marks Cell cycle progression and proliferation despite 4BP-1 dephosphorylation Mol. Cell. Biol. 19 1999 6041 6047
18. K.A. Martin, E.M. Rzucidlo, B.L. Merenick, D.C. Fingar, D.J. Brown, and R.J. Wagner The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation Am. J. Physiol., Cell Physiol. 286 2004 C507 C517
19. 1 progression through p70 S6 kinase-mediated induction of cyclin E expression J. Biol. Chem. 278 2003 35241 35247
20. M. O'Sullivan, S. Scott, N. McCarthy, L.M. Shapiro, P.J. Kirkpatrick, and M.R. Bennett Differential Cyclin E Expression in human in stent stenosis vascular smooth muscle cells identifies targets for selective anti-restenotic therapy Cardiovasc. Res. 60 2003 673 683
21. S. Scott, M. O'Sullivan, S. Hafizi, L.M. Shapiro, and M.R. Bennett Human vascular smooth muscle cells from restenosis or in-stent stenosis sites demonstrate enhanced responses to p53: Implications for brachytherapy and drug treatment for restenosis Circ. Res. 90 2002 398 404
22. 1 receptor blockade Cor. Art Dis. 9 1998 167 175
23. D. Proudfoot, J.N. Skepper, L. Hegyi, M.R. Bennett, C.M. Shanahan, and P.L. Weissberg Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies Circ. Res. 87 2000 1055 1062
24. M.R. Bennett, K. Macdonald, S.W. Chan, J.J. Boyle, and P.L. Weissberg Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques Circ. Res. 82 1998 704 712
25. M.R. Bennett, T.D. Littlewood, S.M. Schwartz, and P.L. Weissberg Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaque to p53-mediated apoptosis Circ. Res. 81 1997 591 599
26. M.R. Bennett, T.D. Littlewood, D.C. Hancock, G.I. Evan, and A.C. Newby Downregulation of the c-myc proto-oncogene-a signal for vascular smooth muscle cell arrest ? Biochem. J. 302 1994 701 709
27. M.R. Bennett, G.I. Evan, and S.M. Schwartz Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways Circ. Res. 77 1995 266 273
28. N. Dyson, and E. Harlow Adenovirus E1A targets key regulators of cell proliferation Cancer Surv. 12 1992 161 195
29. A. Mal, R.Y. Poon, P.H. Howe, H. Toyoshima, T. Hunter, and M.L. Harter Inactivation of p27Kip1 by the viral E1A oncoprotein in TGFbeta-treated cells Nature 380 1996 262 265
30. K. Alevizopoulos, B. Sanchez, and B. Amati Conserved region 2 of adenovirus E1A has a function distinct from pRb binding required to prevent cell cycle arrest by p16INK4a or p27Kip1 Oncogene 19 2000 2067 2074
31. D.C. Fingar, S. Salama, C. Tsou, E. Harlow, and J. Blenis Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E Genes Dev. 16 2002 1472 1487
32. M.R. Bennett, and M. O'Sullivan Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy Pharmacol. Ther. 91 2001 149 166
33. S.O. Marx, T. Jayaraman, L.O. Go, and A.R. Marks Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells Circ. Res. 76 1995 412 417
34. K. Alevizopoulos, J. Vlach, S. Hennecke, and B. Amati Cyclin E and c-Myc promote cell proliferation in the presence of p16INK4a and of hypophosphorylated retinoblastoma family proteins EMBO J. 16 1997 5322 5333
35. M. Stolovich, H. Tang, E. Hornstein, G. Levy, R. Cohen, and S.S. Bae Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation Mol. Cell. Biol. 22 2002 8101 8113
36. A.L. Edinger, and C.B. Thompson Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake Mol. Biol. Cell 13 2002 2276 2288
37. B.K. Law, A. Chytil, N. Dumont, E.G. Hamilton, M.E. Waltner-Law, and M.E. Aakre Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells Mol. Cell. Biol. 22 2002 8184 8198